{"id":"W2908676513","doi":"10.1002/ejhf.1419","title":"Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline","year":2019,"lang":"en","type":"letter","venue":"European Journal of Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Relypsa; Astellas Pharma; University of Toronto; Universität des Saarlandes; Universität Heidelberg; Servier; Institut National de la Santé et de la Recherche Médicale; University of Glasgow; Pfizer; Université de Lorraine; Boston Scientific Corporation; Massachusetts General Hospital; Daiichi Sankyo Europe; Sanofi; Cedars-Sinai Medical Center; Amgen; Eli Lilly and Company; AstraZeneca; ResMed","keywords":"Empagliflozin; Medicine; Heart failure; Canagliflozin; Hazard ratio; Internal medicine; Cardiology; Myocardial infarction; Population; Confidence interval; Diabetes mellitus; Type 2 diabetes; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001525867,0.000505889,0.001542544,0.0002971624,0.0001794184,0.0003937884,0.0002654091,0.0007434439,0.002560591],"category_scores_gemma":[0.000819843,0.0001811716,0.0009997988,0.0002648616,0.0002496642,0.0002722756,0.0002664705,0.001153703,0.0002921874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002171316,"about_ca_system_score_gemma":0.0003104497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007198653,"about_ca_topic_score_gemma":0.001712464,"domain_scores_codex":[0.9996967,0.0001163341,0.00002405554,0.00005001275,0.00006859552,0.00004422748],"domain_scores_gemma":[0.999756,0.00007089925,0.00006779611,0.000022108,0.00002744176,0.00005575299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6668885,0.004956816,0.02790903,0.002921101,0.005991067,0.0002442836,0.00008188096,0.001897195,0.01364818,0.0004573576,0.0114142,0.2635904],"study_design_scores_gemma":[0.4777679,0.1309255,0.3563635,0.0005328744,0.006596145,0.0007024725,0.00005742308,0.004420215,0.006426991,0.001057259,0.01507598,0.00007377356],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.9652772,0.01816531,0.001511598,0.001160663,0.0002650569,0.0007017024,0.004183432,0.0002098966,0.00852514],"genre_scores_gemma":[0.9868621,0.004825084,0.001179528,0.001380712,0.0003449681,0.0007444974,0.002739336,0.00001166455,0.001912165],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.002560591,"threshold_uncertainty_score":0.008566022,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01149744512319028,"score_gpt":0.2383647368167723,"score_spread":0.2268672916935821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}